Health and Fitness Health and Fitness
Fri, June 3, 2011
[ 10:40 AM ] - Market Wire
Medisafe 1 Technologies Announces Three Medical Device Patent Filings
[ 02:35 AM ] - Market Wire
LifeVantage's Nrf2 Activator Reviewed for Tumor P .. tion and Suppression in New Peer-Reviewed Article
Thu, June 2, 2011
[ 07:10 PM ] - Market Wire
AVEOa?s Ficlatuzumab in Combination with Gefiniti .. with Non-Small Cell Lung Cancer; Phase 1b Data Pr
[ 07:10 PM ] - Market Wire
Covidien meldet US-Zulassung im 510(k)-Verfahren .. -Kennzeichnung fr Parietexa" Optimized Composite-
[ 07:10 PM ] - Market Wire
Schiff Nutrition International Acquires Leading P .. obiotic Brands and Rights to Probiotic Technology
[ 07:10 PM ] - Market Wire
Galectin Therapeutics Announces the Appointment o .. reeman and John Mauldin to the Board of Directors
[ 07:10 PM ] - Market Wire
Continucare Corporation to Present at the Jefferies 2011 Global Healthcare Conference
[ 07:10 PM ] - Market Wire
Final Analysis from AVEO Pharmaceuticalsa? Phase .. ents with Advanced Renal Cell Carcinoma Presented
[ 07:10 PM ] - Market Wire
Abiomed to Present at Jefferies 2011 Global Healthcare Conference
[ 07:10 PM ] - Market Wire
Teva Completes Enrollment in Phase III Multiple S .. Evaluating Glatiramer Acetate Three Times Weekly
[ 04:37 PM ] - Market Wire
Health Management Associates, Inc. Appoints Pascal J. Goldschmidt, M.D. to Board of Directors
[ 05:00 AM ] - Market Wire
Nordion CFO to Present at the Jefferies 2011 Global Healthcare Conference
[ 05:00 AM ] - Market Wire
Nordion Builds North America';s First Food-Only Gamma Irradiator
[ 04:00 AM ] - Market Wire
PROTOX REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS AND ACHIEVEMENTS
[ 04:00 AM ] - Market Wire
MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. ent at Jeffries 2011 Global Healthcare Conference
[ 12:20 AM ] - Market Wire
OncoSec Medical Clinical Adviser Will Present Ele .. m Melanoma Clinical Trial at 2011 ASCO Annual Mee
Wed, June 1, 2011
[ 05:57 PM ] - Market Wire
Amedisys Participates in DecisionHealtha?s Opport .. nities for Accountable Care Organizations Webinar
[ 04:40 PM ] - Market Wire
Covidien to Present at Goldman Sachs Conference
[ 04:40 PM ] - Market Wire
Repligen Concludes Pre-NDA Meeting with FDA for RG1068
[ 04:40 PM ] - Market Wire
ARIAD to Present at the Jefferies 2011 Global Healthcare Conference
[ 04:40 PM ] - Market Wire
LabCorp Enters into Definitive Agreement to Acquire Clearstone Central Laboratories
[ 04:40 PM ] - Market Wire
Abiomed Announces Appointment of Paul G. Thomas to Board of Directors
[ 03:39 PM ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Presentation at Jefferies 2011 Global Healthcare Conference
[ 03:39 PM ] - Market Wire
Inhibitex to Present at the Jefferies 2011 Global Healthcare Conference
[ 03:39 PM ] - Market Wire
Data on IPX066 ADVANCE-PD and APEX-PD Phase III S .. International Congress of Parkinsona?s Disease a
[ 03:39 PM ] - Market Wire
Celldex Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference
[ 03:39 PM ] - Market Wire
HealthSpring, Inc. to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
[ 03:39 PM ] - Market Wire
Tenet Management to Present at Jefferies 2011 Global Healthcare Conference on June 6th
[ 03:39 PM ] - Market Wire
Dyax Corp. to Present at the Jefferies Global Healthcare Conference
[ 03:39 PM ] - Market Wire
Biogen Idec to Present at the Jefferies 2011 Global Healthcare Conference

Biogen Idec to Present at the Jefferies 2011 Global Healthcare Conference


Published on 2011-06-01 18:40:30 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Jefferies 2011 Global Healthcare Conference will be webcast live on Monday, June 6, 2011 at 10:30 a.m. ET. To access the live webcast, please visit Biogen Ideca™s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources